Logo

Banc of America Downgrades Sigma-Aldrich in Wake of Advanced Separations Buy

Oct 11, 2006
NEW YORK (GenomeWeb News) – Banc of America Securities has downgraded Sigma-Aldrich from “buy” to “neutral.”
 
On Monday, Sigma said that it had acquired Advanced Separations, a developer of products used in chiral chromatography, for an undisclosed amount.
 
Advanced Separations, based in Whippany, NJ, has annual revenue of $2 million. Sigma said the acquisition will not have a material impact on sales this year, but will be neutral to earnings in 2006 and should help it meet its growth goals over the next several years.
 
As of mid-day Wednesday, Sigma’s shares were down 2.9 percent at $74.94.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.